İmmün Aracılı Nöropatiler ve Guillain-Barre Sendromu
Özet
Referanslar
Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018 Oct 11;4(1):31.
Fadia M, Shroff S, Simpson E. Immune-Mediated Neuropathies. Curr Treat Options Neurol. 2019 Jun 21;21(6):28.
van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). Presse Med. 2013 Jun;42(6 Pt 2):e193-201.
Ryan MM. Pediatric Guillain-Barre Syndrome. Curr Opin Pediatr. 2013 Dec;25(6):689-93.
Doets AY, Verboon C, van den Berg B, et al; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018 Oct 1;141(10):2866-2877.
van Doorn PA, Van den Bergh PYK, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023 Dec;30(12):3646-3674. doi: 10.1111/ene.16073. Epub 2023 Oct 10. PMID: 37814552.
Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020 Mar;25:5-16.
Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008 Sep;15(9):893-908.
